|
Market Cap (4-Jul) $171,348,752 (477th) |
Close (30-Jun) $0.99 |
Volume (30-Jun) 1,077,429 |
Shortsold (19-Jun) 1,473,254 (0.38%) (338th) |
|
52w High $0.66 |
52w Low $0.165 |
P/E - |
EPS -0.05 |
PAR released this announcement to the ASX on 26 August 2022, 9:55. The announcement is not marked as price sensitive, and is 22 page(s) in length and 524.74kb in size.
You can view all announcements from PAR and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAR was 1.684% short sold according to ASIC data. It was ranked the 142nd most shorted stock on the ASX. It remains ranked 338th as of the latest reported data (19 June 2025).
| Other Recent Announcements from PAR | |
|---|---|
| Notification of cessation of securities - PAR | 29 June 2023, 16:43 |
| Primary and Secondary endpoints met in MPS I Trial | 6 June 2023, 12:28 |
| iPPS shows 3-year equivalent durability in OA Canine Study | 1 June 2023, 8:21 |
| Appendix 4G and 2022 Corporate Governance Statement | 26 August 2022, 9:55 |
| 2022 Annual Report and Appendix 4E | 26 August 2022, 8:57 |
| Becoming a substantial holder | 23 August 2022, 8:00 |
| Cleansing Notice | 22 August 2022, 8:07 |
You must be logged in to post a reply.
Paradigm Biopharmaceuticals 